Precision Optics Corporation, Inc. PEYE
We take great care to ensure that the data presented and summarized in this overview for PRECISION OPTICS CORPORATION, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in PEYE
Top Purchases
Top Sells
About PEYE
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use. The company markets its products to original equipment manufacturers through medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Insider Transactions at PEYE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2024
|
Joseph Norman Forkey Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,725
+1.39%
|
$17,227,575
$9987.75 P/Share
|
|
Aug 15
2024
|
Wayne M Coll Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,317
+50.0%
|
$107,903,415
$24995.43 P/Share
|
|
Aug 15
2024
|
Mahesh Lawande Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,726
+50.0%
|
$17,247,918
$9993.54 P/Share
|
|
Dec 30
2023
|
Richard B Miles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.21%
|
$2,000
$2.7 P/Share
|
|
Jun 16
2023
|
Peter V. Anania Director |
BUY
Other acquisition or disposition
|
Direct |
4,827
+2.34%
|
-
|
|
Jan 26
2023
|
Joseph Norman Forkey Chief Executive Officer |
BUY
Acquisition or disposition by will or laws
|
Direct |
4,974
+3.95%
|
-
|
|
Nov 30
2022
|
Peter V. Anania Director |
BUY
Open market or private purchase
|
Indirect |
332
+3.58%
|
$1,992
$6.0 P/Share
|
|
Oct 31
2022
|
Norman H Pessin |
BUY
Open market or private purchase
|
Direct |
79,300
+40.94%
|
$79,300
$1.91 P/Share
|
|
Sep 16
2022
|
Peter V. Anania Director |
BUY
Other acquisition or disposition
|
Direct |
196,821
+50.0%
|
-
|
|
Sep 16
2022
|
Peter V. Anania Director |
SELL
Other acquisition or disposition
|
Indirect |
232,915
-100.0%
|
-
|
|
Sep 07
2022
|
Peter V. Anania Director |
BUY
Other acquisition or disposition
|
Indirect |
8,618
+50.0%
|
-
|
|
Sep 07
2022
|
Peter V. Anania Director |
SELL
Other acquisition or disposition
|
Indirect |
327,133
-100.0%
|
-
|
|
May 31
2022
|
Peter V. Anania Director |
BUY
Other acquisition or disposition
|
Indirect |
232,915
+50.0%
|
-
|
|
May 31
2022
|
Peter V. Anania Director |
SELL
Other acquisition or disposition
|
Indirect |
232,915
-41.59%
|
-
|
|
Mar 02
2022
|
Joseph Norman Forkey Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,000
-4.4%
|
$32,000
$2.25 P/Share
|
|
Mar 02
2022
|
Joseph Norman Forkey Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+7.62%
|
$30,000
$1.2 P/Share
|
|
Feb 28
2022
|
Richard B Miles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,600
+25.07%
|
$7,600
$1.2 P/Share
|
|
Dec 03
2021
|
Daniel S Habhegger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,095
+50.0%
|
$18,190
$2.2 P/Share
|
|
Oct 04
2021
|
Jeffrey Di Rubio VP of Sales and Marketing |
BUY
Open market or private purchase
|
Indirect |
12,500
+50.0%
|
$12,500
$1.6 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 1K shares |
|---|---|
| Open market or private purchase | 7.77K shares |